Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nutrition Surveys | 12 | 2023 | 242 | 0.970 |
Why?
|
| Mental Disorders | 3 | 2023 | 309 | 0.850 |
Why?
|
| Psychometrics | 1 | 2023 | 318 | 0.800 |
Why?
|
| Lactobacillus | 1 | 2020 | 15 | 0.710 |
Why?
|
| Probiotics | 1 | 2020 | 25 | 0.690 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 50 | 0.590 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 63 | 0.580 |
Why?
|
| Liver | 1 | 2020 | 479 | 0.570 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 160 | 0.540 |
Why?
|
| Aging | 2 | 2020 | 664 | 0.510 |
Why?
|
| United States | 19 | 2023 | 4223 | 0.510 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 664 | 0.490 |
Why?
|
| Oxidative Stress | 2 | 2020 | 938 | 0.480 |
Why?
|
| Health Transition | 1 | 2014 | 4 | 0.480 |
Why?
|
| Population Surveillance | 2 | 2013 | 238 | 0.470 |
Why?
|
| Hospitalization | 3 | 2021 | 388 | 0.460 |
Why?
|
| Accidents, Traffic | 1 | 2013 | 42 | 0.460 |
Why?
|
| Adult | 30 | 2023 | 11712 | 0.440 |
Why?
|
| Diabetes Mellitus | 4 | 2016 | 485 | 0.440 |
Why?
|
| Female | 38 | 2023 | 20969 | 0.430 |
Why?
|
| Prevalence | 12 | 2023 | 1455 | 0.430 |
Why?
|
| Male | 32 | 2023 | 20025 | 0.430 |
Why?
|
| Exercise | 1 | 2017 | 613 | 0.410 |
Why?
|
| Brain | 1 | 2020 | 1346 | 0.410 |
Why?
|
| Middle Aged | 27 | 2023 | 10129 | 0.410 |
Why?
|
| California | 13 | 2023 | 476 | 0.410 |
Why?
|
| Glaucoma | 2 | 2023 | 85 | 0.410 |
Why?
|
| Aged | 22 | 2023 | 6741 | 0.410 |
Why?
|
| Brain Injuries | 1 | 2013 | 121 | 0.400 |
Why?
|
| Humans | 43 | 2023 | 37093 | 0.380 |
Why?
|
| Young Adult | 14 | 2023 | 4268 | 0.370 |
Why?
|
| Cross-Sectional Studies | 11 | 2023 | 2721 | 0.360 |
Why?
|
| Albuminuria | 3 | 2020 | 76 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 643 | 0.360 |
Why?
|
| Length of Stay | 2 | 2021 | 185 | 0.320 |
Why?
|
| Self-Injurious Behavior | 2 | 2018 | 24 | 0.300 |
Why?
|
| Birth Weight | 1 | 2007 | 90 | 0.280 |
Why?
|
| Suicide, Attempted | 2 | 2018 | 91 | 0.270 |
Why?
|
| Adolescent | 15 | 2021 | 5363 | 0.260 |
Why?
|
| Age Factors | 5 | 2021 | 1033 | 0.250 |
Why?
|
| Hospital Mortality | 3 | 2021 | 187 | 0.250 |
Why?
|
| Morbidity | 4 | 2017 | 91 | 0.240 |
Why?
|
| Sex Factors | 5 | 2021 | 898 | 0.230 |
Why?
|
| Stomach Neoplasms | 2 | 2016 | 195 | 0.230 |
Why?
|
| Xylans | 2 | 2016 | 23 | 0.230 |
Why?
|
| Factor Analysis, Statistical | 1 | 2023 | 146 | 0.220 |
Why?
|
| Cohort Studies | 3 | 2017 | 1492 | 0.220 |
Why?
|
| Niacin | 1 | 2023 | 22 | 0.220 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 55 | 0.210 |
Why?
|
| Self Concept | 1 | 2023 | 154 | 0.210 |
Why?
|
| Neck Injuries | 2 | 2019 | 10 | 0.210 |
Why?
|
| Vision, Low | 1 | 2022 | 13 | 0.210 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2023 | 74 | 0.210 |
Why?
|
| Iron | 2 | 2015 | 225 | 0.210 |
Why?
|
| Retrospective Studies | 9 | 2023 | 2026 | 0.200 |
Why?
|
| Hospital Charges | 1 | 2021 | 13 | 0.200 |
Why?
|
| Education, Distance | 1 | 2022 | 44 | 0.200 |
Why?
|
| Risk | 3 | 2017 | 267 | 0.190 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 126 | 0.190 |
Why?
|
| Fatty Liver | 1 | 2021 | 64 | 0.190 |
Why?
|
| Schizophrenia | 1 | 2021 | 76 | 0.190 |
Why?
|
| Mexican Americans | 2 | 2021 | 189 | 0.180 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 935 | 0.180 |
Why?
|
| Infant, Newborn | 3 | 2014 | 894 | 0.180 |
Why?
|
| Head Protective Devices | 1 | 2019 | 9 | 0.180 |
Why?
|
| Craniocerebral Trauma | 1 | 2019 | 19 | 0.170 |
Why?
|
| Bicycling | 1 | 2019 | 17 | 0.170 |
Why?
|
| Injury Severity Score | 1 | 2019 | 61 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 149 | 0.170 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 251 | 0.170 |
Why?
|
| Lipid Peroxidation | 1 | 2020 | 140 | 0.170 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 123 | 0.170 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 2019 | 19 | 0.170 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2019 | 30 | 0.170 |
Why?
|
| Pregnancy | 7 | 2017 | 1549 | 0.170 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 494 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2019 | 206 | 0.150 |
Why?
|
| Risk Factors | 9 | 2021 | 3562 | 0.150 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 2379 | 0.140 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 45 | 0.140 |
Why?
|
| Patient Admission | 1 | 2017 | 41 | 0.140 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 161 | 0.140 |
Why?
|
| Stomach | 1 | 2016 | 45 | 0.140 |
Why?
|
| Automobile Driving | 1 | 2016 | 24 | 0.140 |
Why?
|
| Dementia, Vascular | 1 | 2016 | 36 | 0.130 |
Why?
|
| Intention | 1 | 2016 | 94 | 0.130 |
Why?
|
| Databases, Factual | 5 | 2019 | 291 | 0.130 |
Why?
|
| Inpatients | 1 | 2016 | 74 | 0.130 |
Why?
|
| Kidney Diseases | 3 | 2006 | 167 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2021 | 642 | 0.130 |
Why?
|
| Protective Agents | 1 | 2015 | 25 | 0.120 |
Why?
|
| Child | 4 | 2021 | 3131 | 0.120 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 2014 | 1 | 0.120 |
Why?
|
| Obstetrical Forceps | 1 | 2014 | 3 | 0.120 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2014 | 5 | 0.120 |
Why?
|
| Birth Injuries | 1 | 2014 | 9 | 0.120 |
Why?
|
| Mental Health | 1 | 2018 | 303 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2014 | 12 | 0.120 |
Why?
|
| Medical History Taking | 1 | 2014 | 33 | 0.120 |
Why?
|
| Shock, Septic | 1 | 2014 | 20 | 0.120 |
Why?
|
| Incidence | 4 | 2023 | 922 | 0.120 |
Why?
|
| Pregnancy in Diabetics | 1 | 2013 | 4 | 0.120 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 26 | 0.120 |
Why?
|
| Eclampsia | 1 | 2013 | 9 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 233 | 0.110 |
Why?
|
| Vitamin D Deficiency | 2 | 2005 | 105 | 0.110 |
Why?
|
| Substance-Related Disorders | 2 | 2018 | 730 | 0.110 |
Why?
|
| Esophageal Neoplasms | 1 | 2015 | 127 | 0.110 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 12 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2014 | 90 | 0.110 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 14 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2013 | 22 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 47 | 0.110 |
Why?
|
| Socioeconomic Factors | 5 | 2021 | 1067 | 0.110 |
Why?
|
| Medicare | 3 | 2023 | 195 | 0.110 |
Why?
|
| Hypertension | 4 | 2016 | 796 | 0.110 |
Why?
|
| Infant | 2 | 2013 | 1046 | 0.110 |
Why?
|
| Apoptosis | 2 | 2019 | 1398 | 0.100 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2012 | 6 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2014 | 353 | 0.100 |
Why?
|
| Comorbidity | 3 | 2021 | 623 | 0.100 |
Why?
|
| Mice | 2 | 2020 | 5913 | 0.100 |
Why?
|
| Patient Discharge | 3 | 2007 | 93 | 0.100 |
Why?
|
| Los Angeles | 2 | 2017 | 380 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2013 | 1418 | 0.100 |
Why?
|
| Animals | 5 | 2020 | 15081 | 0.100 |
Why?
|
| Odds Ratio | 4 | 2018 | 534 | 0.090 |
Why?
|
| Health Surveys | 3 | 2007 | 373 | 0.090 |
Why?
|
| Reference Values | 2 | 2007 | 212 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 145 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 905 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 190 | 0.080 |
Why?
|
| Parity | 1 | 2007 | 46 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2007 | 20 | 0.070 |
Why?
|
| Hypoglycemia | 1 | 2007 | 17 | 0.070 |
Why?
|
| Gestational Age | 1 | 2007 | 190 | 0.070 |
Why?
|
| Insurance Coverage | 1 | 2007 | 100 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2007 | 126 | 0.070 |
Why?
|
| Methylnitronitrosoguanidine | 2 | 2016 | 6 | 0.070 |
Why?
|
| Pregnancy, Ectopic | 1 | 2005 | 14 | 0.060 |
Why?
|
| Skilled Nursing Facilities | 1 | 2005 | 9 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2016 | 233 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2006 | 134 | 0.060 |
Why?
|
| Pregnancy Outcome | 2 | 2017 | 87 | 0.060 |
Why?
|
| Lipids | 1 | 2006 | 235 | 0.060 |
Why?
|
| Hip Fractures | 1 | 2005 | 23 | 0.060 |
Why?
|
| Vitamin D | 1 | 2007 | 196 | 0.060 |
Why?
|
| Population Groups | 1 | 2005 | 56 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 284 | 0.060 |
Why?
|
| Cultural Diversity | 1 | 2005 | 169 | 0.060 |
Why?
|
| Poverty | 1 | 2006 | 348 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2005 | 208 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 75 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 2023 | 112 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2022 | 47 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2022 | 54 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2021 | 455 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 2014 | 139 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 400 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2019 | 79 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 77 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2019 | 50 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2002 | 646 | 0.040 |
Why?
|
| Obesity | 2 | 2007 | 1067 | 0.040 |
Why?
|
| Chronic Disease | 3 | 2006 | 484 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2002 | 854 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2018 | 32 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 208 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2018 | 53 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 560 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 753 | 0.040 |
Why?
|
| Poisoning | 1 | 2017 | 12 | 0.040 |
Why?
|
| Wounds, Penetrating | 1 | 2017 | 22 | 0.040 |
Why?
|
| Triglycerides | 2 | 2007 | 138 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 352 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2018 | 210 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 225 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 215 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 51 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 77 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2016 | 207 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 152 | 0.030 |
Why?
|
| Attitude | 1 | 2016 | 104 | 0.030 |
Why?
|
| Free Radicals | 1 | 2015 | 74 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2016 | 184 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 157 | 0.030 |
Why?
|
| Vacuum | 1 | 2014 | 5 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2014 | 10 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 435 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 40 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2006 | 583 | 0.030 |
Why?
|
| Cichlids | 1 | 2013 | 4 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 431 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1198 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 36 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2013 | 26 | 0.030 |
Why?
|
| Radiation-Protective Agents | 1 | 2013 | 14 | 0.030 |
Why?
|
| Diet | 1 | 2019 | 801 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2016 | 451 | 0.030 |
Why?
|
| Audiometry | 1 | 2012 | 3 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 286 | 0.030 |
Why?
|
| Survival Rate | 1 | 2013 | 311 | 0.030 |
Why?
|
| Ethiodized Oil | 1 | 2010 | 3 | 0.020 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2010 | 5 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 43 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 31 | 0.020 |
Why?
|
| Students | 1 | 2016 | 519 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2010 | 30 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2010 | 84 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 923 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 286 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 275 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1039 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 128 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 416 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2231 | 0.020 |
Why?
|
| Depression | 1 | 2016 | 712 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1369 | 0.020 |
Why?
|
| Ethanol | 1 | 2010 | 192 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3483 | 0.020 |
Why?
|
| Drug Costs | 1 | 2007 | 28 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2007 | 50 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 41 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2007 | 56 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2006 | 18 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 68 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 97 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 175 | 0.020 |
Why?
|
| Medicaid | 1 | 2007 | 109 | 0.020 |
Why?
|
| Education | 1 | 2005 | 55 | 0.020 |
Why?
|
| Cholesterol | 1 | 2006 | 205 | 0.020 |
Why?
|
| Social Class | 1 | 2007 | 247 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2005 | 34 | 0.020 |
Why?
|
| Data Collection | 1 | 2005 | 194 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 204 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 1378 | 0.010 |
Why?
|
| Indians, North American | 1 | 2005 | 159 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 337 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 52 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2005 | 169 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 596 | 0.010 |
Why?
|